The Wayback Machine - http://web.archive.org./web/20211104201004/https://wn.com/CD34

Latest News for: cd34

Edit

Cell Therapy Market Research Report 2021: T Cells, CD34+ and/or CD133+ Stem Cells, Mesenchymal Stem/Stromal Cells are Predominantly Employed for Clinical Investigation

PR Newswire 22 Oct 2021
T cells, CD34+ and/or CD133+ stem cells, mesenchymal stem/stromal cells are predominantly employed for clinical investigation.The majority of biopharmaceutical entities have been affected by the COVID-19 pandemic, while several cellular therapy development companies have ...
Edit

Minovia Therapeutics Announces Data from Preclinical Studies Demonstrating that Mitochondrial Augmentation of CD34+ cells Confers ...

Business Wire 01 Oct 2021
CAMBRIDGE, Mass. & HAIFA, Israel--(BUSINESS WIRE)--Minovia Therapeutics Announces Data from Preclinical Studies Demonstrating that Mitochondrial Augmentation Technology Confers Functional Benefit ... .
Edit

Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney Disease

Nasdaq Globe Newswire 22 Jun 2021
FDA authorizes new IND for the study of CLBS201 in patients with reduced kidney function. FDA authorizes new IND for the study of CLBS201 in patients with reduced kidney function ... .
Edit

Cell Therapy Platform Demonstrates High Dose CD34+ Cell Performance Characteristics in Patients with Ischemic Heart Failure (Form 8-K) (BioCardia Inc)

Public Technologies 22 Jun 2021
Cell Therapy Platform Demonstrates High Dose CD34+ Cell Performance Characteristics in Patients with Ischemic Heart Failure ... The data demonstrate the high CD34+ cell dosing is being achieved in the ongoing CardiAMP cell therapy heart failure trial ... High doses of CD34+ cells delivered to patients in the CardiAMP Heart Failure Trial.
Edit

bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β⁰/β0 Genotype

Public Technologies 13 Jan 2020
About LentiGlobin for β-Thalassemia (autologous CD34+ cells encoding βA-T87Q-globin gene) ... A genetically modified autologous CD34+ cell enriched population that contains hematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene.
  • 1
×